IFF announced it is one of the first ingredients suppliers to achieve regulatory approval for the use of its 2′-fucosyllactose, or 2′-FL, human milk oligosaccharide, or HMO, in China for infant formula, follow-up formula and formula for special medical purposes for infants.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IFF: